Trial Site Detail
Drug: |
Nilotinib |
|||
|---|---|---|---|---|
Trial: |
Phase II Study Aiming to Evaluate the Efficacy and Safety of Nilotinib Patients With Gastrointestinal Stromal Tumors (GIST) Resistant or Intolerant to Imatinib and or to 2nd Line Tyrosine Kinas (TK) Inhibitor |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
|||
Site name unknown, Tel Hashomer |
Principal Investigator: |
|
|---|---|
Contact: |
|
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Site name unknown, Tel Hashomer Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.